Phase I trial of adjuvant pembrolizumab after radiation therapy for lung-intact malignant pleural mesothelioma

被引:0
|
作者
Ning, M. S. [1 ]
Gandhi, S. [1 ]
Gomez, D. R. [2 ]
Chang, J. Y. [1 ]
Blumenschein, G. [3 ]
Rice, D. [4 ]
O'Reilly, M. [1 ]
Sepesi, B. [5 ]
Lin, S. H. H. [1 ]
Liao, Z. [1 ]
Le, X. [3 ]
Byers, L. A. [3 ]
Mehran, R. [4 ]
Hofstetter, W. [4 ]
Hernandez, M. [6 ]
Chen, Y-S. [1 ]
Jeter, M. [1 ]
Tsao, A. S. [3 ]
机构
[1] UT MD Anderson Canc Ctr, Radiat Oncol, Houston, TX USA
[2] MSKCC Mem Sloan Kettering Canc Ctr, Radiat Oncol, New York, NY USA
[3] UT MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX USA
[4] UT MD Anderson Canc Ctr, Thorac & Cardiovasc Surg, Houston, TX USA
[5] Cardiothorac & Vasc Surg Associates Aurora, HealthOne Phys Grp, Aurora, CO USA
[6] UT MD Anderson Canc Ctr, Biostat, Houston, TX USA
关键词
D O I
10.1016/j.annonc.2024.08.1997
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1915P
引用
收藏
页码:S1115 / S1115
页数:1
相关论文
共 50 条
  • [31] DENDRITIC CELL THERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM): FINAL RESULTS OF A PHASE I/II CLINICAL TRIAL
    Saevels, K.
    Anguille, S.
    Van de Velde, A.
    Snoeckx, A.
    Van Meerbeeck, J.
    Van den Wijngaert, T.
    Lion, E.
    Stein, B.
    Nijs, G.
    Huizing, M.
    Van Tendeloo, V.
    Germonpre, P.
    Smits, E.
    Berneman, Z.
    HAEMATOLOGICA, 2016, 101 : 121 - 121
  • [32] Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs
    Thompson, Marcher R.
    Dumane, Vishruta A.
    Lazarev, Stanislav A.
    Zia, Yaseen
    Rosenzweig, Kenneth E.
    PRACTICAL RADIATION ONCOLOGY, 2019, 9 (03) : E331 - E337
  • [33] Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma
    Yorke, Ellen D.
    Jackson, Andrew
    Kuo, Li Cheng
    Ojo, Anthonia
    Panchoo, Kelly
    Adusumilli, Prasad
    Zauderer, Marjorie G.
    Rusch, Valerie W.
    Shepherd, Annemarie
    Rimner, Andreas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (01): : 61 - 69
  • [34] Predictive Value of Dosimetric Measures on Lung Toxicity in Randomized Trial of Radical RT with Intact Lung in Malignant Pleural Mesothelioma
    Revelant, A.
    Trovo, M.
    Polesel, J.
    Baresic, T.
    Barresi, L.
    Bearz, A.
    Drigo, A.
    Del Conte, A.
    Fontana, P.
    Fanetti, G.
    Caroli, A.
    Franchin, G.
    Minatel, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E490 - E490
  • [35] A PHASE-II TRIAL INVESTIGATING PRIMARY IMMUNOCHEMOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA AND THE FEASIBILITY OF ADJUVANT IMMUNOCHEMOTHERAPY AFTER MAXIMAL CYTOREDUCTION
    PASS, HW
    TEMECK, BK
    KRANDA, K
    STEINBERG, SM
    PASS, HI
    ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (03) : 214 - 220
  • [36] Phase I Trial of Gene Mediated Cytotoxic Immunotherapy (GMCI) for Malignant Pleural Effusion (MPE) and Malignant Pleural Mesothelioma (MPM)
    Sterman, D.
    Haas, A.
    Metzger, S.
    Aguilar, L.
    Aguilar-Cordova, E.
    Manzanera, A.
    Gomez, G.
    Albelda, S.
    Alley, E.
    Evans, T.
    Cohen, R.
    Bauml, J.
    Langer, C.
    Aggarwal, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2150 - S2151
  • [37] The role of radiation therapy in malignant pleural mesothelioma: A systematic review
    Ung, Yee C.
    Yu, Edward
    Falkson, Conrad
    Haynes, Adam E.
    Stys-Norman, Denise
    Evans, William K.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 (01) : 13 - 18
  • [38] COMBINED DOXORUBICIN AND RADIATION-THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA
    SINOFF, C
    FALKSON, G
    SANDISON, AG
    DEMUELENAERE, G
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1605 - 1607
  • [39] Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer
    Welsh, James W.
    Heymach, John V.
    Chen, Dawei
    Verma, Vivek
    Cushman, Taylor R.
    Hess, Kenneth R.
    Shroff, Girish
    Tang, Chad
    Skoulidis, Ferdinandos
    Jeter, Melenda
    Menon, Hari
    Quynh-Nhu Nguyen
    Chang, Joe Y.
    Altan, Mehmet
    Papadimitrakopoulou, Vassiliki A.
    Simon, George R.
    Raju, Uma
    Byers, Lauren
    Glisson, Bonnie
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : 266 - 273
  • [40] Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma
    Steele, JPC
    O'Doherty, CA
    Shamash, J
    Evans, MT
    Gower, NH
    Tischkowitz, MD
    Rudd, RM
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 497 - 499